Ftse Mib
34.183,30
-0,33%
DAX
18.053,27
-0,43%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.514,69
-3,64%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Atea Pharmaceuticals Inc (AVIR) Atea Pharmaceuticals Inc (AVIR) Notizie

Atea Pharmaceuticals Inc

AVIR
3,71
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202413:00GLOBEAtea Announces Presentation of Data Highlighting Favorable..
27/3/202412:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
28/2/202422:18EDGAR2Form 8-K - Current report
28/2/202422:05GLOBEAtea Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202413:00GLOBEAtea Pharmaceuticals to Host Fourth Quarter and Full Year..
03/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:05GLOBEAtea Pharmaceuticals Announces Positive Initial Data from..
03/1/202413:00GLOBEAtea Pharmaceuticals to Present at the 42nd Annual J.P...
13/11/202313:00GLOBEAtea Pharmaceuticals Presents Promising Bemnifosbuvir and..
08/11/202322:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:15EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202313:00GLOBEAtea Pharmaceuticals Announces Participation at Upcoming..
02/11/202312:00GLOBEAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir..
01/11/202312:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2023 Financial..
06/9/202313:00GLOBEAtea Pharmaceuticals to Present at the Morgan Stanley 21st..
08/8/202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:21EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202313:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2023 Financial..
15/6/202313:00GLOBEAtea Pharmaceuticals Announces First Patient Dosed in Phase..
05/6/202322:20GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
30/5/202313:00GLOBEAtea Pharmaceuticals’ Board of Directors Unanimously Rejects..
23/5/202322:05GLOBEAtea Pharmaceuticals Confirms Receipt of Unsolicited..
08/5/202322:05GLOBEAtea Pharmaceuticals Reports First Quarter 2023 Financial..
01/5/202322:05GLOBEAtea Pharmaceuticals to Host First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 3,71

La tua Cronologia

NASDAQ
AVIR
Atea Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network